pirenzepine has been researched along with Tremor in 10 studies
Pirenzepine: An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients.
Tremor: Cyclical movement of a body part that can represent either a physiologic process or a manifestation of disease. Intention or action tremor, a common manifestation of CEREBELLAR DISEASES, is aggravated by movement. In contrast, resting tremor is maximal when there is no attempt at voluntary movement, and occurs as a relatively frequent manifestation of PARKINSON DISEASE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This first clinical study of olanzapine in Japanese patients with schizophrenia was conducted to investigate the efficacy and safety of olanzapine." | 9.09 | Efficacy and safety of olanzapine, an atypical antipsychotic, in patients with schizophrenia: results of an open-label multicenter study in Japan. ( Ishigooka, J; Miura, S; Murasaki, M, 2001) |
| "This first clinical study of olanzapine in Japanese patients with schizophrenia was conducted to investigate the efficacy and safety of olanzapine." | 5.09 | Efficacy and safety of olanzapine, an atypical antipsychotic, in patients with schizophrenia: results of an open-label multicenter study in Japan. ( Ishigooka, J; Miura, S; Murasaki, M, 2001) |
| " Both minaprine and SR 95070B potentiated the tremorigenic effect of oxotremorine without inducing tremor when injected alone." | 3.67 | Cholinomimetic activities of minaprine. ( Biziere, K; Kan, JP; Perio, A; Steinberg, R; Terranova, JP; Worms, P, 1989) |
| " In a between-groups dosing design, five separate groups of rats received vehicle, clozapine 1." | 1.30 | Similarities and differences between the subchronic and withdrawal effects of clozapine and olanzapine on forelimb force steadiness. ( Fowler, SC; Stanford, JA, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 5 (50.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sun, T | 1 |
| Ma, T | 1 |
| Ho, IK | 1 |
| Stanford, JA | 1 |
| Fowler, SC | 1 |
| Watanabe, T | 1 |
| Kakefuda, A | 1 |
| Tanaka, A | 1 |
| Takizawa, K | 1 |
| Hirano, S | 1 |
| Shibata, H | 1 |
| Yamagiwa, Y | 1 |
| Yanagisawa, I | 1 |
| Strauss, AJ | 1 |
| Bailey, RK | 1 |
| Dralle, PW | 1 |
| Eschmann, AJ | 1 |
| Wagner, RB | 1 |
| al-Mulhim, A | 1 |
| Atwal, S | 1 |
| Coupland, NJ | 1 |
| Mayorga, AJ | 1 |
| Cousins, MS | 1 |
| Trevitt, JT | 2 |
| Conlan, A | 1 |
| Gianutsos, G | 1 |
| Salamone, JD | 2 |
| Carlson, BB | 1 |
| Hirose, H | 1 |
| Aoki, I | 1 |
| Kimura, T | 1 |
| Fujikawa, T | 1 |
| Numazawa, T | 1 |
| Sasaki, K | 1 |
| Sato, A | 1 |
| Hasegawa, T | 1 |
| Nishikibe, M | 1 |
| Mitsuya, M | 1 |
| Ohtake, N | 1 |
| Mase, T | 1 |
| Noguchi, K | 1 |
| Ishigooka, J | 1 |
| Murasaki, M | 1 |
| Miura, S | 1 |
| Worms, P | 1 |
| Kan, JP | 1 |
| Steinberg, R | 1 |
| Terranova, JP | 1 |
| Perio, A | 1 |
| Biziere, K | 1 |
1 trial available for pirenzepine and Tremor
| Article | Year |
|---|---|
Efficacy and safety of olanzapine, an atypical antipsychotic, in patients with schizophrenia: results of an open-label multicenter study in Japan.
Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Anxiety; Benzodiazepines; Female; Humans; Japa | 2001 |
9 other studies available for pirenzepine and Tremor
| Article | Year |
|---|---|
Differential modulation of muscarinic receptors in the rat brain by repeated exposure to methyl parathion.
Topics: Acetylcholinesterase; Animals; Autoradiography; Brain; Cholinesterase Inhibitors; Down-Regulation; H | 2003 |
Similarities and differences between the subchronic and withdrawal effects of clozapine and olanzapine on forelimb force steadiness.
Topics: Animals; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Clozapine; | 1997 |
Synthesis and biological evaluation of phenylacetyl derivatives having low central nervous system permeability as potent and selective M2 muscarinic receptor antagonists.
Topics: Animals; Bradycardia; Cerebral Cortex; Dibenzazepines; Dogs; Heart; Male; Mice; Muscarinic Antagonis | 1998 |
Conventional psychotropic-induced tremor extinguished by olanzapine.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Female; Fluphenazine; Haloperidol; Humans; Male; Menta | 1998 |
Provocation of obsessive-compulsive behaviour and tremor by olanzapine.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Female; Humans; Obsessive-Compulsive Disorder; Olanzap | 1998 |
Characterization of the muscarinic receptor subtype mediating pilocarpine-induced tremulous jaw movements in rats.
Topics: Animals; Corpus Striatum; Diamines; Dose-Response Relationship, Drug; Jaw; Male; Muscarinic Agonists | 1999 |
Effects of H1 antagonists on cholinomimetic-induced tremulous jaw movements: studies of diphenhydramine, doxepin, and mepyramine.
Topics: Animals; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Benzodiazepines; Cholinergic Agents | 2000 |
Pharmacological properties of (2R)-N-[1-(6-aminopyridin-2-ylmethyl)piperidin-4-yl]-2-[(1R)-3,3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: a novel mucarinic antagonist with M(2)-sparing antagonistic activity.
Topics: Animals; Benzeneacetamides; Brain; Bronchoconstriction; Heart Atria; Heart Rate; Humans; In Vitro Te | 2001 |
Cholinomimetic activities of minaprine.
Topics: Animals; Atropine; Avoidance Learning; Behavior, Animal; Female; Guinea Pigs; In Vitro Techniques; M | 1989 |